Literature DB >> 11350097

Increased levels of soluble adhesion molecules, E-selectin and P-selectin, in patients with infective endocarditis and embolic events.

S Korkmaz1, M Ileri, I Hisar, E Yetkin, F Kosar.   

Abstract

AIMS: Inflammation-induced procoagulant changes and endothelial cell activation appear to play an important role in thromboembolic complications of infective endocarditis. Hence, the aim of this study was to compare the plasma levels of soluble adhesion molecules E- and P-selectin in infective endocarditis patients with and without embolic events, and healthy subjects. METHODS AND
RESULTS: The study group consisted of 76 consecutive patients (mean age=26 years old, range from 8 to 64 years) with definite infective endocarditis according to the Duke criteria. Thirteen of the patients (17.1%) had embolic events. Transoesophageal echocardiographic examinations were performed on all patients within 3 days of initiation of antimicrobial therapy. Although there was a trend towards a higher rate of vegetations detected in those with embolic events than in those without, this did not reach statistical significance (84.6% vs 80.9%, P>0.05). Significantly larger vegetations were observed in patients with embolic events as compared to those without embolic events (1.4 cm vs 1.0 cm, P=0.03). The mean plasma concentrations of P-selectin were elevated in patients with embolic events as compared to both patients without embolic events and control subjects (58.69+/-7.49 ng x ml(-1)vs 29.65+/-5.69 ng x ml(-1), P=<0.001 and 58.69+/- 7.49 ng x ml(-1) vs 25.82+/-5.38 ng x ml(-1), P<0.001). Similarly, the patients with embolic events had increased plasma levels of E-selectin compared to those without embolic events and the control group (73.15+/-11.47 ng x ml(-1) vs 42.84+/-8.77 ng x ml(-1), P<0.001 and 73.15+/- 11.47 ng x ml(-1) vs 34.23+/-5.92 ng x ml(-1), P<0.001).
CONCLUSION: Determination of these membrane activation molecules may provide useful markers with which to identify patients at high thromboembolic risk from infective endocarditis. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350097     DOI: 10.1053/euhj.2000.2401

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  The role of hemostasis in infective endocarditis.

Authors:  Emanuele Durante-Mangoni; Rosa Molaro; Domenico Iossa
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

2.  Staphylococcal endocarditis presenting with a renal infarct in a patient with acute lymphoblastic leukemia.

Authors:  Meong Hi Son; Eun Sil Park; Ji-Hyun Seo; Jae-Young Lim; Chan-Hoo Park; Hyang-Ok Woo; Hee-Shang Youn
Journal:  Cancer Res Treat       Date:  2008-09-30       Impact factor: 4.679

Review 3.  [Neurological complications of infective endocarditis].

Authors:  K Angstwurm; A C Borges; E Halle; E Schielke; J R Weber
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

4.  Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk.

Authors:  Franck Thuny; Gilbert Habib; Yvan Le Dolley; Matthias Canault; Jean-Paul Casalta; Monique Verdier; Jean-François Avierinos; Didier Raoult; Jean-Louis Mege; Pierre-Emmanuel Morange; Marie-Christine Alessi
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

5.  Soluble endothelial selectin in acute lung injury complicated by severe pneumonia.

Authors:  Daisuke Osaka; Yoko Shibata; Kazunori Kanouchi; Michiko Nishiwaki; Tomomi Kimura; Hiroyuki Kishi; Shuichi Abe; Sumito Inoue; Yoshikane Tokairin; Akira Igarashi; Keiko Yamauchi; Yasuko Aida; Takako Nemoto; Keiko Nunomiya; Koji Fukuzaki; Isao Kubota
Journal:  Int J Med Sci       Date:  2011-05-11       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.